Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results

Rhea-AI Summary

Cue Health Inc. (HLTH) will announce its Q4 and full-year 2023 financial results on March 13, 2024. The company will host a conference call and webcast to discuss the results and recent highlights. Participants can register in advance for the call and access it via telephone or webinar.

SAN DIEGO--(BUSINESS WIRE)-- Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Cue Health

Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cue’s customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 test, which became the first home use respiratory test to receive this FDA approval. Cue also received Emergency Use Authorization from the FDA for its molecular Mpox test at the point-of-care and, to expand its test menu, the company has a number of other submissions under review by the FDA. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240228029129/en/

Press

Cue Health

press@cuehealth.com



Investors

ICR Westwicke

Caroline Corner

+1-415-202-5678

caroline.corner@westwicke.com

Source: Cue Health Inc.

FAQ

When will Cue Health Inc. (HLTH) release its Q4 and full-year 2023 financial results?

Cue Health Inc. (HLTH) will release its Q4 and full-year 2023 financial results on Wednesday, March 13, 2024.

What time will Cue Health Inc. (HLTH) host the conference call and webcast?

Cue Health Inc. (HLTH) will host the conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on March 13, 2024.

How can participants access the live call via telephone?

Participants can access the live call via telephone by registering in advance using the provided link in the press release.

Where can participants access the live webinar of the call?

Participants can access the live webinar of the call by visiting the Events section of Cue Health Inc.'s website at investors.cuehealth.com.

Will there be a replay of the webinar available?

Yes, a replay of the webinar will be available on Cue Health Inc.'s website shortly after the conclusion of the call.